ELK1 and neoplasm: The activity of MEKs, MAPKs, and ELK1 was found significantly suppressed and xenografts studies also revealed that tumor growth was limited as well, indicting a direct link between ELK1’s deactivation by EGFR blocking and antitumor effects [302].